Global Hormone Replacement Therapy Market 2015-2019 Key Trends, Size, Growth, Shares and Forecast Research Report

Submitted by: Submitted by

Views: 10

Words: 983

Pages: 4

Category: Business and Industry

Date Submitted: 11/18/2015 11:44 PM

Report This Essay

Researchmoz added Most up-to-date research on "Global Hormone Replacement Therapy Market 2015-2019" to its huge collection of research reports.

Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route of administration (oral, parenteral, and transdermal), and by geography (the Americas, EMEA, and APAC). The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market, including F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and Pfizer.

An overview of the hormone replacement therapy market

Hormone replacement therapy involves the replacement of the hormones in the body whose levels have become low, in case of women nearing menopause or patient with growth hormone deficiency due to conditions such as dwarfism. At present, the combination of drugs are used to treat the conditions, which are known to have a better safety and efficacy parameter. Unmet medical needs is one of the major drivers influencing the growth of the market. Therefore, the need for new treatment options with better safety results to accommodate the current unmet need is huge.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=459130

In 2014, the Americas dominated the market, where the majority of the contribution was from the US, and this trend is expected to continue during the forecast period. However, the market in the APAC region is witnessing a rapid growth, hence, there is a vast opportunity for vendors to venture into this region. Technavio expects the global hormone replacement therapy market to grow at a moderate rate, posting a CAGR of over 2% during the forecast period.

Segmentation of the hormone replacement therapy market by type of hormonal therapy

Estrogen replacement therapy

Growth hormone replacement therapy

With a...